Skip to content

Application of the Patient-reported Longitudinal Assessment Tool for OSA (PLATO) Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea

Application of the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07789834
Acronym
APQ-OAT
Enrollment
20
Registered
2026-08-27
Start date
2026-09-01
Completion date
2027-02-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea (OSA), Oral Applliance Therapy

Keywords

Obstructive Sleep Apnea, Observational, Real World Study, PLATO Questionnaire, Oral Appliance Therapy

Brief summary

Prospective, real-world observational study in a dental sleep practice to assess the feasibility of incorporating the PLATO into a dental sleep practice and applicability for patients who are undergoing oral appliance therapy for the treatment of obstructive sleep apnea(OSA). The PLATO questionnaire was recently developed by the American Academy of Sleep Medicine specifically for use in patients with obstructive sleep apnea.

Interventions

OTHERThe study will assess the feasibility of incorporating the PLATO questionnaire into a dental sleep practice. The PLATO questionnaire was developed as a patient reported outcome measure

The primary outcome will be to assess the difference in pre and post (within subject) scores on the PLATO questionnaire in a population of patients with a diagnosis of obstructive sleep apnea who will be treated with an oral appliance.

Sponsors

Nevada Dental Sleep
Lead SponsorOTHER
Panthera Dental
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion Criteria * All ethnicities and genders * 18 years of age * AHI ≥5 ≤ 30 * Dentally suitable for OAT * AHI \> 30 if refusal or intolerance for CPAP therapy * Smartphone ( for home sleep test) * Only using oral appliance therapy (i.e., no combination therapy)

Exclusion criteria

* Pregnancy * Use of home oxygen * Serious/uncontrolled illness (such as angina/myocardial infarction, cancer, stroke, dementia, congestive heart failure, chronic respiratory illness), significant sleep-related disorder) * The investigator feels, for any reason, that the patient's participation may not be in their best interests * Any condition or circumstance that, in the opinion of the investigator, is likely to preclude study completion, prevent accurate data collection, or bias the results

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of the PLATO questionnaire at the completion of the oral appliance titration period.The time from enrollment unit completion is as follows: Initial assessment to device delivery 10-30 days, after delivery the time depends on the participants response, which can be between 30-90 days.The PLATO questionnaire is a patient reported outcome measure. The questionnaire will be completed prior to the beginning of the therapy, until the dental practitioner, based on subjective and objective measures determine that the optimum position to treat the sleep apnea has been attained. Minimum Value: 0 Maximum Value: 50 Outcome Interpretation: Higher scores indicate a worse outcome (more severe obstructive sleep apnea symptoms and greater daytime fatigue)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026